Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 4/2008

01-04-2008 | Case Report

Oral bisphosphonates in treatment of transient osteoporosis

Authors: L. Kibbi, Z. Touma, N. Khoury, T. Arayssi

Published in: Clinical Rheumatology | Issue 4/2008

Login to get access

Abstract

Transient osteoporosis is a rare clinical syndrome of unknown etiology. It is believed that this syndrome is self-limiting; however, the data in the literature support the use of anti-resorptive agents that may reduce pain and decrease the duration of the illness. Herein, we describe two cases of transient osteoporosis of the hip and one case of transient osteoporosis of the knee where the use of oral bisphosphonates provided successful objective and subjective outcome.
Literature
1.
Lakhanpal S et al (1987) Transient regional osteoporosis. A study of 56 cases and review of the literature. Ann Intern Med 106(3):444–450PubMed
2.
Samdani A, Lachmann E, Nagler W (1998) Transient osteoporosis of the hip during pregnancy: a case report. Am J Phys Med Rehabil 77(2):153–156PubMedCrossRef
3.
Miltner O et al (2003) Transient osteoporosis of the navicular bone in a runner. Arch Orthop Trauma Surg 123(9):505–508PubMedCrossRef
4.
Bruinsma BJ, LaBan MM (1990) The ghost joint: transient osteoporosis of the hip. Arch Phys Med Rehabil 71(5):295–298PubMed
5.
Bramlett KW et al (1987) Transient osteoporosis.. Clin Orthop Relat Res 222:197–202PubMed
6.
7.
Bijl M, van Leeuwen MA, van Rijswijk MH (1999) Transient osteoporosis of the hip: presentation of (a)typical cases and a review of the literature. Clin Exp Rheumatol 17(5):601–604PubMed
8.
Ben-David Y et al (1991) Transient osteoporosis of the hip during pregnancy. A case report. J Reprod Med 36(9):672–674PubMed
9.
Urbanski SR, de Lange EE, Eschenroeder HC Jr (1991) Magnetic resonance imaging of transient osteoporosis of the hip. A case report. J Bone Joint Surg Am 73(3):451–455PubMed
10.
Hayes CW, Conway WF, Daniel WW (1993) MR imaging of bone marrow edema pattern: transient osteoporosis, transient bone marrow edema syndrome, or osteonecrosis. Radiographics 13(5):1001–1011 (discussion 1012)PubMed
11.
Parker RK, Ross GJ, Urso JA (1997) Transient osteoporosis of the knee. Skeletal Radiol 26(5):306–309PubMedCrossRef
12.
Trevisan C et al (2002) Regional migratory osteoporosis: a pathogenetic hypothesis based on three cases and a review of the literature. Clin Rheumatol 21(5):418–425PubMedCrossRef
13.
Varenna M et al (2002) Intravenous pamidronate in the treatment of transient osteoporosis of the hip. Bone 31(1):96–101PubMedCrossRef
14.
Schapira D et al (2003) Severe transient osteoporosis of the hip during pregnancy. Successful treatment with intravenous biphosphonates.. Clin Exp Rheumatol 21(1):107–110PubMed
15.
Ringe JD, Dorst A, Faber H (2005) Effective and rapid treatment of painful localized transient osteoporosis (bone marrow edema) with intravenous ibandronate. Osteoporos Int 16(12):2063–2068PubMedCrossRef
16.
Arayssi TK et al (2003) Calcitonin in the treatment of transient osteoporosis of the hip. Semin Arthritis Rheum 32(6):388–397PubMedCrossRef
17.
Varenna M et al (1996) Transient osteoporosis of the hip: a densitometric study. Clin Rheumatol 15(2):169–173PubMedCrossRef
18.
La Montagna G et al (2005) Successful neridronate therapy in transient osteoporosis of the hip. Clin Rheumatol 24(1):67–69PubMedCrossRef
Metadata
Title
Oral bisphosphonates in treatment of transient osteoporosis
Authors
L. Kibbi
Z. Touma
N. Khoury
T. Arayssi
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 4/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0766-z

Other articles of this Issue 4/2008

Clinical Rheumatology 4/2008 Go to the issue

Original Article

Change in serum uric acid between baseline and 1-year follow-up and its associated factors in male subjects

Original Article

Diagnosis delay in patients with ankylosing spondylitis: possible reasons and proposals for new diagnostic criteria

Case Report

Visceral leishmaniasis in a patient with psoriatic arthritis treated with infliximab: reactivation of a latent infection?

Original Article

Etanercept in the treatment of rheumatoid arthritis: clinical follow-up over one year by ultrasonography

Brief Report

Anticitrulline peptide antibodies (CCP3) in leprosy sera: a negative association

Brief Report

Histological changes in bone marrow after treatment of infliximab for rheumatoid arthritis
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits